摘要:
Compounds of general formula (Ia) or (Ib) or (Ic) or (Id), wherein the R groups are each independently selected from the group consisting of hydrogen, acyl, alkyl, alkenyl, alkynyl, aryl, -CONH2, alkali metal, and sugar, and their use for the treatment of cancers.
摘要:
Die vorliegende Erfindung betrifft eine Verbindung mit der Formel (1), wobei R1 bis R8, die gleich oder unabhängig voneinander verschieden sein können, jeweils aus der Gruppe, die aus Wasserstoff und dem Rest –(CH 2 ) k –X besteht, wobei k eine ganze Zahl von 1 bis 20 ist und wobei X ein organischer Rest, der a) wenigstens ein neutrales, protonierbares Stickstoffatom und/oder b) wenigstens ein positiv geladenes Stickstoffatom enthält, ist, ausgewählt wird, mit der Maßgabe, dass mindestens 1 Rest R1 bis R8 nicht Wasserstoff ist, sowie deren Herstellung und Verwendung.
摘要:
Compounds of general formula (Ia) or (Ib) or (Ic) or (Id), wherein the R groups are each independently selected from the group consisting of hydrogen, acyl, alkyl, alkenyl, alkynyl, aryl, -CONH 2 , alkali metal, and sugar, and their use for the treatment of cancers.
摘要:
Compounds useful for selectively eliminating senescent cells, compositions comprising same and uses thereof in treating diseases and disorders in which selective elimination of senescent cells is beneficial are provided. The compounds are selectively represented by the following Formulae (I) and (II); with the variables being as defined in the specification. Also provided is a screening assay for identifying compounds that selectively inhibit senescent cells.
摘要:
An actinic ray-sensitive or radiation-sensitive resin composition comprising any of the compounds of general formula (I) below; wherein: Ar represents an aromatic ring that may have a substituent other than the -(A-B) groups; n is an integer of 1 or greater; A represents any one, or a combination of two or more members selected from a single bond, an alkylene group, -O-, -S-, -C(=O)-, -S(=O)-, -S(=O)? 2 - and OS(=O) 2 -, provided that -C(=O)O- is excluded; B represents a group containing a hydrocarbon group having 4 or more carbon atoms wherein either a tertiary or a quaternary carbon atom is contained, when n is 2 or greater, the two or more -(A-B) groups may be identical to or different from each other; and M + represents an organic onium ion.
摘要:
The invention relates to a group of novel benzimidazolone and quinazolinone derivatives which are agonists on human ORL1 (nociceptin) receptors. The invention also relates to the preparation of these compounds, to pharmaceutical compositions containing a pharmacologically active amount of at least one of these imidazolone and quinazolinone derivatives as an active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of disorders in which ORL1 receptors are involved. The invention relates to compounds of the general formula (1): wherein the symbols have the meanings as given in the description.